Pharmacological blockade of CB1R suppresses hunger and induces hypophagia, and the CB1R-antagonist Rimonabant in the past has been proposed for the treatment of obesity [40,41,42]. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.